Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Chopas James George has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $99K.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 6.2K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 16.1K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 9.4K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 4.2K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 2.4K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 8.1K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 8.1K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 16.1K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 16.1K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 8.4K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 8.4K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | D — Derivative transaction | 5.6K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 5.6K | — | |
| 2026-05-14 | APLS | Apellis Pharmaceuticals, Inc. | J — Other acquisition / disposition | 66.0K | — | |
| 2026-01-30 | APLS | Apellis Pharmaceuticals, Inc. | A — Grant or award | 16.1K | $0.00 | |
| 2026-01-23 | APLS | Apellis Pharmaceuticals, Inc. | S — Open-market sale | 2.1K | $21.77 | $45K |
| 2026-01-21 | APLS | Apellis Pharmaceuticals, Inc. | S — Open-market sale | 726 | $19.79 | $14K |
| 2026-01-15 | APLS | Apellis Pharmaceuticals, Inc. | S — Open-market sale | 873 | $22.19 | $19K |
| 2025-09-15 | APLS | Apellis Pharmaceuticals, Inc. | S — Open-market sale | 189 | $24.19 | $5K |
| 2025-09-02 | APLS | Apellis Pharmaceuticals, Inc. | S — Open-market sale | 548 | $28.08 | $15K |
Chopas James George is a corporate insider — currently tracked as Insider of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($99K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chopas James George profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.